MaxLinear Inc (MXL)
Official siteTECHNOLOGY • SEMICONDUCTORS • NASDAQ
Market Cap: $5.06B
Last updated: Nov 17, 2026 at 11:06 AM ET
MaxLinear Inc (MXL) Stock Forecast
Analysts expect MaxLinear (MXL) to earn $1.99 per share in the fiscal year ending Dec 31, 2026, on revenue of $774.32M. Of 11 analysts, 7 rate the stock Buy or Strong Buy, 4 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 9 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 11 ratings average 2.27, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 64% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 9.1% |
| Buy | 6 | 54.5% |
| Hold | 4 | 36.4% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 11
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 116.1% and revenue estimates rise 64.0%.
- Fiscal year ending Dec 31, 2026
- $1.99
- EPS consensus, revenue $774.32M
- Fiscal year ending Dec 31, 2027
- $4.30
- EPS consensus, revenue $1.27B
- Next report
- Jan 27, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.99 | $1.97 to $2.01 | 10 | $774.32M | $773.10M to $777.00M | 10 |
| Dec 31, 2027 | $4.30 | $1.95 to $4.77 | 11 | $1.27B | $801.32M to $1.37B | 11 |
Quarterly Estimates
The EPS consensus rises from $0.79 for the quarter ending Dec 31, 2026 to $0.95 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.79 | $0.76 to $0.83 | 11 | $252.78M | $244.02M to $265.65M | 11 |
| Mar 31, 2027 | $0.95 | $0.36 to $1.04 | 11 | $286.27M | $177.26M to $305.00M | 11 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 28 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 9 | 0 |
| Fiscal year ending Dec 31, 2027 | 10 | 0 |
| Quarter ending Mar 31, 2027 | 9 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 13.7% from $1.75.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $1.99 | $1.75 | $1.75 | $1.75 | $1.75 | +13.8% |
| Fiscal year ending Dec 31, 2027 | $4.30 | $2.61 | $2.61 | $2.58 | $2.58 | +66.4% |
| Quarter ending Mar 31, 2027 | $0.95 | $0.56 | $0.56 | $0.56 | $0.56 | +70.1% |
Frequently Asked Questions About MXL
What is the MXL stock forecast?
Consensus analyst estimates put MaxLinear's EPS at $1.99 for the fiscal year ending Dec 31, 2026, on revenue of $774.32M. The consensus rating from 11 analysts is Buy.
How do analysts rate MXL stock?
Of 11 analysts covering MaxLinear, 1 rates it Strong Buy, 6 Buy, 4 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from MXL next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $1.99, with estimates from $1.97 to $2.01 from 10 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $4.30, with estimates from $1.95 to $4.77 from 11 analysts.
What revenue do analysts expect from MaxLinear next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $774.32M, with estimates from $773.10M to $777.00M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.27B, with estimates from $801.32M to $1.37B.
How many analysts cover MXL?
11 analysts rate MaxLinear stock, and 10 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
MXL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors